JP2024529476A5 - - Google Patents
Info
- Publication number
- JP2024529476A5 JP2024529476A5 JP2024505183A JP2024505183A JP2024529476A5 JP 2024529476 A5 JP2024529476 A5 JP 2024529476A5 JP 2024505183 A JP2024505183 A JP 2024505183A JP 2024505183 A JP2024505183 A JP 2024505183A JP 2024529476 A5 JP2024529476 A5 JP 2024529476A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- optionally substituted
- pharmaceutically acceptable
- acceptable salt
- substitutable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163227206P | 2021-07-29 | 2021-07-29 | |
| US63/227,206 | 2021-07-29 | ||
| US17/479,248 | 2021-09-20 | ||
| US17/479,248 US11325916B1 (en) | 2021-07-29 | 2021-09-20 | Spiropyrrolidine derived antiviral agents |
| US202263324367P | 2022-03-28 | 2022-03-28 | |
| US63/324,367 | 2022-03-28 | ||
| PCT/US2022/024772 WO2023009187A1 (en) | 2021-07-29 | 2022-04-14 | Novel spiropyrrolidine derived antiviral agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529476A JP2024529476A (ja) | 2024-08-06 |
| JP2024529476A5 true JP2024529476A5 (cg-RX-API-DMAC10.html) | 2025-03-05 |
Family
ID=85087186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024505183A Pending JP2024529476A (ja) | 2021-07-29 | 2022-04-14 | 新規スピロピロリジン誘導抗ウイルス剤 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4376834A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024529476A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240044452A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022319598A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3173702A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL310246A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2024001377A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023009187A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7559223B2 (ja) | 2020-08-24 | 2024-10-01 | ギリアード サイエンシーズ， インコーポレイテッド | リン脂質化合物及びその使用 |
| TWI925033B (zh) | 2020-10-16 | 2026-05-11 | 美商基利科學股份有限公司 | 磷脂化合物及其用途 |
| WO2023283256A1 (en) | 2021-07-09 | 2023-01-12 | Aligos Therapeutics, Inc. | Anti-viral compounds |
| AU2023303408A1 (en) | 2022-07-06 | 2024-12-19 | Aligos Therapeutics, Inc. | Anti-viral compounds |
| EP4612156A1 (en) * | 2022-11-02 | 2025-09-10 | Aligos Therapeutics, Inc. | Anti-viral compounds |
| CN119139307B (zh) * | 2023-12-29 | 2025-09-23 | 上海柯君医药科技有限公司 | 螺环类化合物在制备3CLpro蛋白酶抑制剂或药物中的用途 |
| WO2025221657A1 (en) * | 2024-04-15 | 2025-10-23 | Aligos Therapeutics, Inc. | Anti-viral compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006061714A2 (en) * | 2004-12-09 | 2006-06-15 | Pfizer Inc. | Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis |
| US8222288B2 (en) * | 2006-08-30 | 2012-07-17 | The Regents Of The University Of Michigan | Small molecule inhibitors of MDM2 and the uses thereof |
| CA2661354C (en) * | 2006-08-30 | 2012-12-18 | The Regents Of The University Of Michigan | New small molecule inhibitors of mdm2 and the uses thereof |
| US8575208B2 (en) * | 2007-02-27 | 2013-11-05 | Vertex Pharmaceuticals Incorporated | Inhibitors of serine proteases |
| UY37381A (es) * | 2016-08-30 | 2018-03-23 | Glaxosmithkline Ip No 2 Ltd | Compuestos que inhiben proteasas 3c y 3cl y métodos de uso de los mismos |
| US12398147B2 (en) * | 2021-05-11 | 2025-08-26 | Enanta Pharmaceuticals, Inc. | Macrocyclic spiropyrrolidine derived antiviral agents |
| US11325916B1 (en) * | 2021-07-29 | 2022-05-10 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| WO2023086400A1 (en) * | 2021-11-12 | 2023-05-19 | Enanta Pharmaceuticals, Inc. | Novel spiropyrrolidine derived antiviral agents |
| WO2023125825A1 (en) * | 2021-12-29 | 2023-07-06 | Shanghai Curegene Pharmaceutical Co., Ltd. | Anticoronviral compounds and compositions and uses thereof |
-
2022
- 2022-04-14 IL IL310246A patent/IL310246A/en unknown
- 2022-04-14 JP JP2024505183A patent/JP2024529476A/ja active Pending
- 2022-04-14 CA CA3173702A patent/CA3173702A1/en active Pending
- 2022-04-14 MX MX2024001377A patent/MX2024001377A/es unknown
- 2022-04-14 KR KR1020247006429A patent/KR20240044452A/ko active Pending
- 2022-04-14 AU AU2022319598A patent/AU2022319598A1/en active Pending
- 2022-04-14 EP EP22850031.0A patent/EP4376834A4/en active Pending
- 2022-04-14 WO PCT/US2022/024772 patent/WO2023009187A1/en not_active Ceased